» Articles » PMID: 6780101

Release of Vasoactive Intestinal Peptide in the Dumping Syndrome

Overview
Specialty General Medicine
Date 1981 Feb 14
PMID 6780101
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the effect of gastric surgery on the plasma vasoactive intestinal peptide (VIP) concentration, 13 patients with gastrectomy and seven controls were given an oral hypertonic load (200 ml 50% glucose solution). Blood was taken at intervals during the test for measurement of VIP and blood glucose concentrations and packed cell volume. At the same time observations were made on the occurrence of dumping symptoms and a record kept of the pulse rate. VIP values in the patients with gastrectomy were significantly increased by glucose ingestion, while these did not alter in controls (p less than 0.001). There was a highly significant correlation between the rate of rise in plasma VIP concentration and the rates of rise in packed cell volume (r = 0.85; p less than 0.001) and blood glucose concentration (r = 0.76; p less than 0.01) in patients with gastrectomy. Changes in packed cell volume and blood glucose values and the occurrence of dumping symptoms during the test were significantly different when postoperative patients were compared with controls (p less than 0.001, p less than 0.005, and p less than 0.001 respectively). Furthermore, when the patients with gastrectomy were divided into those without symptoms and those with dumping after meals the latter group showed a significantly greater rise of VIP (p less than 0.05). Despite the increased plasma VIP concentrations observed during dumping, VIP cannot be taken as the sole factor in the pathogenesis of the dumping syndrome.

Citing Articles

Dumping Syndrome: A Review of the Current Concepts of Pathophysiology, Diagnosis, and Treatment.

Berg P, McCallum R Dig Dis Sci. 2015; 61(1):11-8.

PMID: 26396002 DOI: 10.1007/s10620-015-3839-x.


A possible role of GLP-1 in the pathophysiology of early dumping syndrome.

Yamamoto H, Mori T, Tsuchihashi H, Akabori H, Naito H, Tani T Dig Dis Sci. 2006; 50(12):2263-7.

PMID: 16416173 DOI: 10.1007/s10620-005-3046-2.


Sympathoadrenal activation and the dumping syndrome after gastric surgery.

Mehagnoul-Schipper D, Lenders J, Willemsen J, Hopman W Clin Auton Res. 2001; 10(5):301-8.

PMID: 11198486 DOI: 10.1007/BF02281113.


Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. An update.

Lamers C, Bijlstra A, Harris A Dig Dis Sci. 1993; 38(2):359-64.

PMID: 8425449 DOI: 10.1007/BF01307556.


Gastric emptying after surgery for the dumping syndrome.

Harries A, Dew M, Crawley E, Leach K, Salaman J, Rhodes J Postgrad Med J. 1984; 60(705):458-60.

PMID: 6462993 PMC: 2417949. DOI: 10.1136/pgmj.60.705.458.


References
1.
Le Quesne L, Hobsley M, HAND B . The dumping syndrome. I. Factors responsible for the symptoms. Br Med J. 1960; 1(5167):141-7. PMC: 1966306. DOI: 10.1136/bmj.1.5167.141. View

2.
Bloom S . Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: value of measurement in diagnosis and treatment. Am J Dig Dis. 1978; 23(4):373-6. DOI: 10.1007/BF01072425. View

3.
Zeitlin I, Smith A . 5-hydroxyindoles and kinins in the carcinoid and dumping syndromes. Lancet. 1966; 2(7471):986-91. DOI: 10.1016/s0140-6736(66)92924-2. View

4.
Bloom S, Polak J, Pearse A . Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet. 1973; 2(7819):14-6. DOI: 10.1016/s0140-6736(73)91947-8. View

5.
Holohan K, Murphy R, Flanagan R, Buchanan K, ELMORE D . Enzymic iodination of the histidyl residue of secretin: a radioimmunoassay of the hormone. Biochim Biophys Acta. 1973; 322(1):178-80. DOI: 10.1016/0005-2795(73)90190-6. View